Smart Wearable Ozone Therapy System for Managing Multidrug‐Resistant Wound Infections
Advanced Therapeutics · 2026-03 · 9 (3)
DOI: 10.1002/adtp.202500541 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Therapeutics, online erschienen am 10.03.2026. Verfasst von Akshay Krishnakumar und 10 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute of Food and Agriculture, National Institute of Diabetes and Digestive and Kidney Diseases.
Abstract (Originalsprache)
Multidrug‐resistant (MDR) bacterial infections represent a critical challenge in wound care, leading to treatment failure, prolonged healing, and increased morbidity and mortality worldwide. Among MDR pathogens, Pseudomonas aeruginosa is particularly problematic due to its adaptive resistance mechanisms, underscoring the urgent need for alternative, non‐antibiotic therapeutic strategies. Ozone has demonstrated potent antimicrobial efficacy while promoting wound healing and exhibiting a low propensity for resistance development; however, conventional ozone delivery systems are bulky, poorly suited for ambulatory use, and pose risks of environmental leakage and unintended exposure. To address these limitations, we have developed a smart wearable ozone therapy system capable of precise, localized ozone delivery directly to the wound bed. The platform integrates on‐demand ozone generation, real‐time sensing, and controlled air circulation within a compact, reusable unit, coupled to a disposable wound interface patch via double‐lumen tubing. Embedded sensors continuously regulate ozone concentrations within therapeutic windows while detecting leakage and triggering automatic shutdown to ensure patient and environmental safety. System characterization demonstrated that localized low‐level ozone exposure (75 ppm), when combined with Vancomycin (400 µg·mL − 1 ), eradicated planktonic bacterial cultures to undetectable levels within 4 h while maintaining minimal cytotoxicity toward mammalian cells. For the first time, this fully integrated wearable platform was validated in a Pseudomonas aeruginosa– infected porcine wound model, achieving approximately 90% bacterial reduction after four consecutive daily 6 h treatments and accelerating wound closure by nearly threefold compared with silver dressings or topical antibiotic treatment alone. These results establish a safe, effective, and translationally viable wearable ozone therapy system for the management of MDR‐infected wounds.
Förderung
- National Institute of Food and Agriculture
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Krishnakumar, A., Roth, A., Srinivasan, P., Rana, M. M., Gallina, N. L. F., Sarnaik, D., McCain, R. R., Cox, A. D., Seleem, M. N., Bhunia, A. K., & Rahimi, R. (2026). Smart Wearable Ozone Therapy System for Managing Multidrug‐Resistant Wound Infections. Advanced Therapeutics, 9(3). https://doi.org/10.1002/adtp.202500541
Vancouver
Krishnakumar A, Roth A, Srinivasan P, Rana MM, Gallina NLF, Sarnaik D, et al. Smart Wearable Ozone Therapy System for Managing Multidrug‐Resistant Wound Infections. Advanced Therapeutics. 2026;9(3). doi:10.1002/adtp.202500541
BibTeX
@article{Krishnakumar2026,
author = {Krishnakumar, Akshay and Roth, Alexander and Srinivasan, Praveen and Rana, Muhammad Masud and Gallina, Nicholas L. F. and Sarnaik, Devendra and McCain, Robyn R. and Cox, Abigail D. and Seleem, Mohamed N. and Bhunia, Arun K. and Rahimi, Rahim},
title = {Smart Wearable Ozone Therapy System for Managing Multidrug‐Resistant Wound Infections},
journal = {Advanced Therapeutics},
year = {2026},
volume = {9},
number = {3},
doi = {10.1002/adtp.202500541}
}
EUVIMED